Home Clovis

Clovis

In operation
IPO Delisting
Biopharmaceutical Manufacturer

Basic Information

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing, and commercializing cancer treatments in the United States, Europe, and other international markets. Their development programs target specific cancer subtypes, combining precision medicine with companion diagnostics to guide treatment for patients most likely to benefit.
Clovis Oncology, Inc.
Colorado,United States of America
101~500 people
January 01, 2009
businessdevelopment@clovisoncology.com.